Suchergebnisse - "De Luca, Annamaria"

PubPharm (9)

1

227th ENMC International Workshop: : Finalizing a plan to guarantee quality in translational research for neuromuscular diseases Heemskerk, Netherlands, 10-11 February 2017

enthalten in: Neuromuscular disorders : NMD | 2018

von Willmann, R. | Buccella, F. | De Luca, A. | +29

2

Facilitating orphan drug development : Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA

enthalten in: Neuromuscular disorders : NMD | 2017

von Hoffman, E. | Workshop Participants | TREAT-NMD Alliance | +44

3

Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy

enthalten in: Neuromuscular disorders : NMD | 2015

von Lynn, S. | Aartsma-Rus, A. | Bushby, K. | +13

4

Searching for novel anti-myotonic agents : pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide

enthalten in: Neuromuscular disorders : NMD | 2012

von De Luca, A. | De Bellis, M. | Corbo, F. | +5

5

Enhancing translation : guidelines for standard pre-clinical experiments in mdx mice

enthalten in: Neuromuscular disorders : NMD | 2012

von Willmann, R. | De Luca, A. | Benatar, M. | +5

6

First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant

enthalten in: Neuromuscular disorders : NMD | 2006

von Burdi, R. | Didonna, M. | Pignol, B. | +9

7

Prednisone in dystrophin-deficient Caernorabditis elegans

enthalten in: Neuromuscular disorders : NMD | 2004

von De Luca, A.

CommentOn: Neuromuscul Disord. 2004 Jun;14(6):365-70. - PMID 15145337

8

New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse

enthalten in: Neuromuscular disorders : NMD | 2004

von De Luca, A. | Pierno, S. | Liantonio, A. | +10

9

Pre-clinical trials in Duchenne dystrophy : what animal models can tell us about potential drug effectiveness

enthalten in: Neuromuscular disorders : NMD | 2002

von De Luca, A. | Pierno, S. | Liantonio, A. | +1

1
[1]